Safety and tolerability of extended (96 weeks) treatment with peginterferon alfa-2a [40kd] in genotype D patients with HBeAg-negative chronic hepatitis B

Authors
Publication date
1 October 2010
Publisher
'Ovid Technologies (Wolters Kluwer Health)'

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    AIR Universita degli studi di Milano

    redirect
    oaioai:air.unimi.it:2434/150875
    Last time updated on 06/03/2019